Poland· PL-100446900
Roclanda
A latanoprost and netarsudil product containing latanoprostum + netarsudilum, registered in Poland by Santen Oy. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Latanoprost and netarsudil is registered in 14 of 19 countries.
Countries holding a registration under ATC S01EE51 (latanoprost and netarsudil), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Latanoprost and netarsudil · ATC S01EE51
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Latanoprostum + Netarsudilum
- Manufacturer
- Santen Oy
- Country
- Poland (PL)
- ATC code
- S01EE51
- ATC class
- Latanoprost and netarsudil
- Defined daily dose
- 0.1 ml, AT
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin04987084326713
- gtin04987084327031
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Latanoprost and netarsudil in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesRocklatanAlcon Laboratories, Inc.
- CzechiaROCLANDASanten OY, Tampere
- SpainROCLANDA 50 MICROGRAMOS/ML + 200 MICROGRAMOS/ML COLIRIO EN SOLUCIONSanten Oy
- FinlandRoclandaParanova Oy
- United KingdomRoclanda 50micrograms/ml + 200micrograms/ml eye dropsSanten UK Ltd
- NorwayRoclandaSanten Oy
- SwitzerlandRoclanda, collyre en solutionSanten SA
- IcelandRoclandaSanten Oy*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Roclanda
- Liechtenstein · Roclanda
- Norway · Roclanda
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f21609c4-5364-4d86-a17b-604822058138 GET /v1/drugs/f21609c4-5364-4d86-a17b-604822058138?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople do oczu, roztwór",
"source": "urpl",
"strength": "50 mcg/ml + 200 mcg/ml",
"packaging": "04987084326713 ¦ Rpz ¦ EU/1/20/1502/001 ¦ 139085\n1 butelka 2,5 ml\nRpz ¦ EU/1/20/1502/002 ¦ 150051\n3 butelki 2,5 ml\n04987084327031 ¦ Rpz ¦ EU/1/20/1502/003 ¦ 167131\n1 butelka 2,5 ml\nRpz ¦ EU/1/20/1502/004 ¦ 167132\n3 butelki 2,5 ml",
"substance": "Latanoprostum 50 mcg/ml + Netarsudilum 200 mcg/ml",
"common_name": "Latanoprostum + Netarsudilum",
"pl_product_id": "100446900",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about latanoprost and netarsudil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.